☰

Maryse Lapeyre-Mestre - Publications

Affiliations: 
Toulouse 3 
Tree Info Similar researchers PubMed Report error

313 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lapeyre-Mestre M, Fabre F, Jouanjus E. From the first pilot initiatives in the early 1990s to the national OSIAP survey in the 2020s: More than 30years of insight in medication diversion phenomenon in France. Therapie. PMID 39521721 DOI: 10.1016/j.therap.2024.10.053  0.652
2024 Clarke L, Castor-Newton MJ, Jalles C, Lapeyre-Mestre M, Gardette V. Potentially avoidable hospitalizations and associated factors among older people in French Guiana using the French National Health Data System. International Journal For Quality in Health Care : Journal of the International Society For Quality in Health Care. 36. PMID 39136470 DOI: 10.1093/intqhc/mzae083  0.606
2024 Couret A, Gardette V, Renoux A, Lapeyre-Mestre M. Impact of modifications to antidementia drug reimbursement in France: Analysis of the FRA-DEM cohort. British Journal of Clinical Pharmacology. PMID 38925159 DOI: 10.1111/bcp.16143  0.612
2024 Maillard O, Bun R, Laanani M, Verga-Gérard A, Leroy T, Gault N, Estellat C, Noize P, Kaguelidou F, Sommet A, Lapeyre-Mestre M, Fourrier-Réglat A, Weill A, Quantin C, Tubach F. Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase. Therapie. PMID 38834394 DOI: 10.1016/j.therap.2024.05.003  0.466
2024 Lépine B, Debin M, Dassieu L, Gimenez L, Palmaro A, Ponté C, Swital M, Lapeyre-Mestre M, Blanchon T, Dupouy J. GPs' practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network. Therapie. PMID 38729825 DOI: 10.1016/j.therap.2024.04.002  0.598
2024 Couret A, Lapeyre-Mestre M, Renoux A, Gardette V. Healthcare use according to deprivation among French Alzheimer's Disease and Related Diseases subjects: a national cross-sectional descriptive study based on the FRA-DEM cohort. Frontiers in Public Health. 12: 1284542. PMID 38487186 DOI: 10.3389/fpubh.2024.1284542  0.591
2024 Bordet C, Zureik M, Zelmat Y, Lafaurie M, Lapeyre-Mestre M, Sommet A, Mazieres J, Despas F. Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study. Cancer Treatment and Research Communications. 39: 100801. PMID 38447474 DOI: 10.1016/j.ctarc.2024.100801  0.448
2024 Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V. Which factors preceding dementia identification impact future healthcare use trajectories: multilevel analyses in administrative data. Bmc Geriatrics. 24: 89. PMID 38263052 DOI: 10.1186/s12877-023-04643-1  0.605
2023 Barus R, Montastruc F, de Canecaude C, Bagheri H, Sommet A, Lapeyre-Mestre M. Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study. Expert Opinion On Drug Safety. 22: 1283-1287. PMID 37584264 DOI: 10.1080/14740338.2023.2247962  0.506
2022 Clarke L, Castor-Newton MJ, Angénieux O, Lapeyre-Mestre M, Gardette V. [Not Available]. Sante Publique (Vandoeuvre-Les-Nancy, France). 34: 695-707. PMID 36577668 DOI: 10.3917/spub.225.0695  0.574
2022 Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V. Healthcare use patterns before Alzheimer's disease and related diseases identification and future healthcare trajectory. International Journal of Geriatric Psychiatry. 38: e5849. PMID 36457190 DOI: 10.1002/gps.5849  0.59
2022 Lépine B, Debin M, Dassieu L, Gimenez L, Palmaro A, Ponté C, Swital M, Lapeyre-Mestre M, Blanchon T, Dupouy J. Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network. Journal of Substance Abuse Treatment. 143: 108891. PMID 36215914 DOI: 10.1016/j.jsat.2022.108891  0.604
2022 Revol B, Lapeyre-Mestre M, Fouilhé Sam-Laï N, Jouanjus E. Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database. British Journal of Clinical Pharmacology. PMID 35665950 DOI: 10.1111/bcp.15430  0.656
2022 Roussin A, Soeiro T, Fouque C, Jouanjus E, Frauger E, Fouilhé N, Mallaret M, Micallef J, Lapeyre-Mestre M. Increase of high-risk tramadol use and harmful consequences in France from 2013-2018: evidence from the triangulation of addictovigilance data. British Journal of Clinical Pharmacology. PMID 35318713 DOI: 10.1111/bcp.15323  0.623
2022 Lafaurie M, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risk of Immune Thrombocytopenia After Influenza Vaccine. Jama Internal Medicine. 182: 444-445. PMID 35188544 DOI: 10.1001/jamainternmed.2021.8523  0.442
2022 Lavergne J, Debin M, Blanchon T, Colizza V, Dassieu L, Gimenez L, Kengne-Kuetche C, Lapeyre-Mestre M, Dupouy J. Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France. European Journal of Pain (London, England). 26: 729-739. PMID 34958720 DOI: 10.1002/ejp.1901  0.632
2021 Moulis G, Germain J, Rueter M, Lafaurie M, Aroichane M, Comont T, Mahévas M, Viallard JF, Chèze S, Ebbo M, Audia S, Leclerc-Teffahi S, Sommet A, Beyne-Rauzy O, Michel M, ... ... Lapeyre-Mestre M, et al. Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study. American Journal of Hematology. PMID 34779031 DOI: 10.1002/ajh.26404  0.475
2021 Jouanjus E, Gibaja V, Fabre F, Lapeyre-Mestre M. Medical prescription forms of opioid cough suppressants falsified by the patients before and after they switched from OTC to prescription-only in France. British Journal of Clinical Pharmacology. PMID 34427950 DOI: 10.1111/bcp.15052  0.671
2021 Lafaurie M, Maquet J, Baricault B, Ekstrand C, Christiansen CF, Linder M, Bahmanyar S, Nørgaard M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study. British Journal of Haematology. PMID 34386974 DOI: 10.1111/bjh.17709  0.487
2021 Maquet J, Lafaurie M, Walter O, Sailler L, Sommet A, Lapeyre-Mestre M, Michel M, Moulis G. Epidemiology of autoimmune hemolytic anemia: a nationwide population-based study in France. American Journal of Hematology. PMID 33930203 DOI: 10.1002/ajh.26213  0.449
2021 Gallini A, Jegou D, Lapeyre-Mestre M, Couret A, Bourrel R, Ousset PJ, Fabre D, Andrieu S, Gardette V. Development and Validation of a Model to Identify Alzheimer's Disease and Related Syndromes in Administrative Data. Current Alzheimer Research. PMID 33882802 DOI: 10.2174/1567205018666210416094639  0.661
2021 Tambon M, Ponté C, Jouanjus E, Fouilhé N, Micallef J, Lapeyre-Mestre M. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance. Frontiers in Psychiatry. 12: 639780. PMID 33613345 DOI: 10.3389/fpsyt.2021.639780  0.675
2020 De Almeida Chaves S, Derumeaux H, Do Minh P, Lapeyre-Mestre M, Moulis G, Pugnet G. Assessment of the Accuracy of Using Codes to Identify Systemic Sclerosis. Clinical Epidemiology. 12: 1355-1359. PMID 33324109 DOI: 10.2147/CLEP.S260733  0.503
2020 Mongiatti M, Bayle P, Lagarrigue A, Fabre D, Telmon N, Lapeyre-Mestre M, Jouanjus E. The cardiovascular health of prisoners who use cannabis: An exploratory study among hospitalised prisoners. Therapie. PMID 32718583 DOI: 10.1016/J.Therap.2020.06.017  0.653
2020 Lapeyre-Mestre M, Boucher A, Daveluy A, Gibaja V, Jouanjus E, Mallaret M, Peyrière H, Micallef J. Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Therapie. PMID 32660776 DOI: 10.1016/J.Therap.2020.06.006  0.661
2020 Souty C, Launay T, Steichen O, Conte C, Turbelin C, Sarazin M, Vilcu AM, Rossignol L, Blanchon T, Lapeyre-Mestre M, Hanslik T. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions. European Journal of Clinical Pharmacology. PMID 32632714 DOI: 10.1007/S00228-020-02952-7  0.367
2020 Barthez S, Revet A, Chouchana L, Jonville-Bera AP, Pizzoglio V, Raynaud JP, Chebane L, Lapeyre-Mestre M, Montastruc F. Adverse drug reactions in infants, children and adolescents exposed to antidepressants: a French pharmacovigilance study. European Journal of Clinical Pharmacology. PMID 32588107 DOI: 10.1007/S00228-020-02944-7  0.332
2020 Moulis G, Comont T, Germain J, Sommet A, Lapeyre-Mestre M, Beyne-Rauzy O, Adoue D. Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry. Blood Advances. 4: 1974-1977. PMID 32384539 DOI: 10.1182/Bloodadvances.2020001664  0.483
2020 Poncet M, Gardette V, Couret A, Renoux A, Lapeyre-Mestre M, Gallini A. Benzodiazepine exposure in subjects with incident Alzheimer's disease and related syndromes in France: a longitudinal study 2011-2017. International Clinical Psychopharmacology. PMID 32324610 DOI: 10.1097/Yic.0000000000000312  0.647
2020 Couret A, Gallini A, Poncet M, Renoux A, Lapeyre-Mestre M, Gardette V. Benzodiazepine Dispensing to Persons With Dementia in France, 2011-2016: A Nationwide Study. Journal of the American Medical Directors Association. PMID 32299715 DOI: 10.1016/J.Jamda.2020.02.019  0.615
2020 Lapeyre-Mestre M. The challenges of pharmacoepidemiology of orphan drugs in rare diseases. Therapie. PMID 32164974 DOI: 10.1016/J.Therap.2020.02.013  0.383
2020 Dupouy J, Maumus-Robert S, Mansiaux Y, Pariente A, Lapeyre-Mestre M. Primary Care of Opioid use Disorder: The End of "the French Model"? European Addiction Research. 1-9. PMID 32155620 DOI: 10.1159/000506630  0.637
2020 Lafaurie M, Baricault B, Soler V, Cassagne M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. No increased risk of cataract in adult patients with primary immune thrombocytopenia treated with eltrombopag. A French nationwide nested case-control study. British Journal of Haematology. PMID 32155284 DOI: 10.1111/Bjh.16561  0.463
2020 Gernigon C, Othenin J, Michaud A, Vayr F, Rousseau V, Montastier E, Lapeyre-Mestre M, Niezborala M, Hérin F. Évaluation de la consommation médicamenteuse d’une population de travailleurs de la région Toulousaine en 2016 Archives Des Maladies Professionnelles Et De L'Environnement. 81: 81. DOI: 10.1016/J.Admp.2019.12.051  0.305
2020 Lapeyre-Mestre M. Consommation de médicaments en milieu de travail : un marqueur de santé de la population ? Archives Des Maladies Professionnelles Et De L'Environnement. 81: 61-62. DOI: 10.1016/J.Admp.2019.12.008  0.312
2019 Lapeyre-Mestre M. Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies. Eclinicalmedicine. 17: 100216. PMID 31891147 DOI: 10.1016/J.Eclinm.2019.11.009  0.35
2019 Pugnet G, Mounié M, Lapeyre-Mestre M, Moulis G, Sailler L. [Insufficient influenza vaccination coverage in giant cell arteritis. A French population-based study]. La Revue De Medecine Interne. 41: 446-450. PMID 31883837 DOI: 10.1016/J.Revmed.2019.12.009  0.538
2019 de Germay S, Montastruc F, Carvajal A, Lapeyre-Mestre M, Montastruc JL. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database. Parkinsonism & Related Disorders. 70: 55-59. PMID 31865063 DOI: 10.1016/J.Parkreldis.2019.12.011  0.335
2019 Andre L, Gallini A, Montastruc F, Montastruc JL, Piau A, Lapeyre-Mestre M, Gardette V. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review. European Journal of Clinical Pharmacology. PMID 31468067 DOI: 10.1007/S00228-019-02744-8  0.653
2019 Jouanjus E, Lapeyre-Mestre M, Nodot M, Roussin A, Franchitto N, Boyes JP, Nasr N, Oustric S, Dupouy J. Teaching Basic Knowledge on Substance Use Disorders: the Impact of e-Learning on Health Professionals. Clinical Therapeutics. PMID 31395392 DOI: 10.1016/J.Clinthera.2019.07.012  0.753
2019 Floyd JS, Bloch KM, Brody JA, Maroteau C, Siddiqui MK, Gregory R, Carr DF, Molokhia M, Liu X, Bis JC, Ahmed A, Liu X, Hallberg P, Yue QY, Magnusson PKE, ... ... Lapeyre-Mestre M, et al. Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing. Plos One. 14: e0218115. PMID 31242253 DOI: 10.1371/Journal.Pone.0218115  0.319
2019 Jouanjus E, Micallef J, Mallaret M, Lapeyre-Mestre M. Generalizing the use of a multidimensional approach to move towards an effective Addictovigilance. The International Journal of Neuropsychopharmacology. PMID 31194866 DOI: 10.1093/Ijnp/Pyz033  0.667
2019 Coutens B, Mouledous L, Stella M, Rampon C, Lapeyre-Mestre M, Roussin A, Guiard BP, Jouanjus E. Lack of correlation between the activity of the mesolimbic dopaminergic system and the rewarding properties of pregabalin in mouse. Psychopharmacology. PMID 30879119 DOI: 10.1007/S00213-019-05198-Z  0.639
2019 Conte C, Vaysse C, Bosco P, Noize P, Fourrier-Reglat A, Despas F, Lapeyre-Mestre M. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology. Therapie. PMID 30824175 DOI: 10.1016/J.Therap.2018.09.076  0.339
2019 Dupui M, Micallef J, Lapeyre-Mestre M. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution. Therapie. PMID 30798951 DOI: 10.1016/J.Therap.2018.09.078  0.335
2019 Lapeyre-Mestre M, Montastruc F. Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs. Therapie. PMID 30792079 DOI: 10.1016/J.Therap.2018.12.010  0.377
2019 Driot D, Jouanjus E, Oustric S, Dupouy J, Lapeyre-Mestre M. Patterns of gabapentin and pregabalin use and misuse: results of a population-based cohort study in France. British Journal of Clinical Pharmacology. PMID 30737829 DOI: 10.1111/Bcp.13892  0.746
2019 de Germay S, Rueter M, Montastruc F, Rousseau V, Lapeyre-Mestre M, Montastruc JL. Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database. Fundamental & Clinical Pharmacology. PMID 30687946 DOI: 10.1111/Fcp.12450  0.37
2019 Lafaurie M, Baricault B, Soler V, Cassagne M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study Blood. 134: 2363-2363. DOI: 10.1182/Blood-2019-124729  0.547
2019 Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risk of Immune Thrombocytopenia Induced By Influenza Vaccine. a Nationwide Population-Based Study in France Blood. 134: 1086-1086. DOI: 10.1182/Blood-2019-124720  0.537
2019 Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risque de purpura thrombopénique immunologique après vaccination contre la grippe. Étude populationnelle en France La Revue De MéDecine Interne. 40: A55. DOI: 10.1016/J.Revmed.2019.10.050  0.559
2019 Lafaurie M, Baricault B, Soler V, Cassagne M, Sailler L, Lapeyre-Mestre M, Sommet A, Moulis G. Risque de cataracte associé à l’exposition à l’eltrombopag dans le traitement de la thrombopénie immunologique. Étude populationnelle en France La Revue De MéDecine Interne. 40: A41. DOI: 10.1016/J.Revmed.2019.10.026  0.565
2019 Moulis G, Rueter M, Lafaurie M, Lapeyre-Mestre M. Eltrombopag dans le traitement du purpura thrombopénique immunologique de l’adulte : étude de « vraie vie » en France. Résultats intermédiaires de l’étude ELEXTRA La Revue De MéDecine Interne. 40: A40-A41. DOI: 10.1016/J.Revmed.2019.10.025  0.315
2019 Comont T, Brun N, Germain J, Dingremont C, Castel B, Arista S, Madaule S, Montané De La Roque P, Prudhomme L, Sailler L, Balardy L, Alric L, Gaches F, Lapeyre-Mestre M, Beyne-Rauzy O, et al. Rentabilité diagnostique du myélogramme systématique chez les patients de plus de 60 ans au diagnostic de purpura thrombopénique immunologique pour rechercher une cause secondaire La Revue De MéDecine Interne. 40: A38-A39. DOI: 10.1016/J.Revmed.2019.10.022  0.309
2018 Caudrelier L, Moulis G, Lapeyre-Mestre M, Sailler L, Pugnet G. Validation of giant cell arteritis diagnosis code in the French hospital electronic database. European Journal of Internal Medicine. 60: e16-e17. PMID 30448032 DOI: 10.1016/J.Ejim.2018.10.004  0.534
2018 Montastruc JL, Benevent J, Montastruc F, Bagheri H, Despas F, Lapeyre-Mestre M, Sommet A. What is pharmacoepidemiology? Definition, methods, interest and clinical applications. Therapie. PMID 30389102 DOI: 10.1016/J.Therap.2018.08.001  0.588
2018 Jouanjus E, Falcou A, Deheul S, Roussin A, Lapeyre-Mestre M. Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study. Pharmacoepidemiology and Drug Safety. PMID 30255533 DOI: 10.1002/Pds.4624  0.677
2018 Mounié M, Pugnet G, Savy N, Lapeyre-Mestre M, Molinier L, Costa N. Additional costs of polymyalgia rheumatica with giant-cell arteritis. Arthritis Care & Research. PMID 30156754 DOI: 10.1002/Acr.23736  0.477
2018 Lafaurie M, Pochard L, Lotiron C, Molinier L, Lapeyre-Mestre M, Jouanjus E. Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital. Clinical Drug Investigation. PMID 30047105 DOI: 10.1007/S40261-018-0679-4  0.683
2018 Montastruc F, Khosrow-Khavar F, de Germay S, Renoux C, Rousseau V, Durrieu G, Montastruc M, Rascol O, Sommet A, Lapeyre-Mestre M, Benevent J, Montastruc JL. Tamoxifen and the risk of Parkinsonism: a case/non-case study. European Journal of Clinical Pharmacology. PMID 29862427 DOI: 10.1007/S00228-018-2496-3  0.514
2018 Patras de Campaigno E, Kebir I, Montastruc JL, Rueter M, Maret D, Lapeyre-Mestre M, Sallerin B, Despas F. Correction to: Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase. Drug Safety. PMID 29737500 DOI: 10.1007/S40264-018-0672-0  0.369
2018 de Germay S, Lapeyre-Mestre M, Montastruc JL, Montastruc F. [Atropinic burden and anticholinergic drugs: Interest and application in clinical practice in the elderly]. Therapie. PMID 29625707 DOI: 10.1016/J.Therap.2018.02.010  0.395
2018 Kaguelidou F, Sommet A, Lapeyre-Mestre M. Use of French healthcare insurance databases in pediatric pharmacoepidemiology. Therapie. PMID 29588074 DOI: 10.1016/J.Therap.2017.11.008  0.559
2018 Moulis F, Durrieu G, Lapeyre-Mestre M. Off-label and unlicensed drug use in children population. Therapie. PMID 29580614 DOI: 10.1016/J.Therap.2018.02.002  0.354
2018 Moulis G, Pugnet G, Costedoat-Chalumeau N, Mathian A, Leroux G, Boutémy J, Espitia O, Bouillet L, Berthier S, Gaultier JB, Jeandel PY, Konaté A, Mékinan A, Solau-Gervais E, Terrier B, ... ... Lapeyre-Mestre M, et al. Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study. Annals of the Rheumatic Diseases. PMID 29535124 DOI: 10.1136/Annrheumdis-2017-212705  0.539
2018 Rwagitinywa J, Lapeyre-Mestre M, Bourrel R, Montastruc JL, Sommet A. Comparison of adherence to generic multi-tablet regimens versus brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients. Fundamental & Clinical Pharmacology. PMID 29505661 DOI: 10.1111/Fcp.12363  0.551
2018 Couderc S, Lapeyre-Mestre M, Bourrel R, Carle P, Montastruc JL, Sommet A. Infectious risk of biological drugs versus traditional systemic treatments in moderate to severe psoriasis: a cohort analysis in the French insurance database. Fundamental & Clinical Pharmacology. PMID 29446857 DOI: 10.1111/Fcp.12358  0.588
2018 Jouanjus E, Guernec G, Lapeyre-Mestre M. Medical prescriptions falsified by the patients: a twelve-year national monitoring to assess prescription drug diversion. Fundamental & Clinical Pharmacology. PMID 29436015 DOI: 10.1111/Fcp.12356  0.683
2018 Rwagitinywa J, Sommet A, Palmaro A, Montastruc JL, Lapeyre-Mestre M. Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction. Health Policy (Amsterdam, Netherlands). PMID 29398158 DOI: 10.1016/J.Healthpol.2018.01.002  0.561
2018 Pochard L, Dupouy J, Frauger E, Giocanti A, Micallef J, Lapeyre-Mestre M. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Fundamental & Clinical Pharmacology. PMID 29337399 DOI: 10.1111/Fcp.12346  0.659
2018 Moulis G, Baricault B, Ekstrand C, Lafaurie M, Christiansen CF, Linder M, Bahmanyar S, Nørgaard M, Sailler L, Lapeyre-Mestre M. Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study Blood. 132: 3745-3745. DOI: 10.1182/Blood-2018-99-112506  0.303
2018 Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risk of Vaccine-Induced Immune Thrombocytopenia in Children. Nationwide Case Cross-over and Self-Controlled Case Series Studies in France Blood. 132: 738-738. DOI: 10.1182/Blood-2018-99-110522  0.518
2018 Moulis G, Baricault B, Ekstrand C, Lafaurie M, Christiansen C, Linder M, Bahnmanyar S, Norgaard M, Lapeyre-Mestre M, Sailler L. Facteurs de risque de thrombose dans le purpura thrombopénique immunologique primaire de l’adulte. Résultats dans une cohorte nationale française (étude RiFT-ITP) La Revue De MéDecine Interne. 39: A37. DOI: 10.1016/J.Revmed.2018.10.276  0.317
2017 Montastruc F, Bagheri H, Lacroix I, Damase-Michel C, Chebane L, Rousseau V, Jouanjus E, Lapeyre-Mestre M, Durrieu G, Montastruc JL. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting. Drug Safety. PMID 29270770 DOI: 10.1007/S40264-017-0630-2  0.685
2017 Rioufol C, Lamy S, Conte C, Jeanneau P, Compaci G, Delpierre C, Lapeyre-Mestre M, Laurent G, Despas F. Non-cancer drug consumption during the early trajectory of lymphoma survivorship. Therapie. PMID 29229217 DOI: 10.1016/J.Therap.2017.10.007  0.311
2017 Rwagitinywa J, Lapeyre-Mestre M, Bourrel R, Sommet A. Generic antiretroviral drug use in HIV-infected patients: A cohort study from the French health insurance database. Therapie. PMID 29195713 DOI: 10.1016/J.Therap.2017.10.001  0.566
2017 Fuzier R, Serres I, Bourrel R, Palmaro A, Lapeyre-Mestre M. Analgesic Drug Prescription After Carpal Tunnel Surgery: A Pharmacoepidemiological Study Investigating Postoperative Pain. Regional Anesthesia and Pain Medicine. PMID 29099415 DOI: 10.1097/Aap.0000000000000685  0.308
2017 Mounié M, Costa N, Sailler L, Lapeyre-Mestre M, Bourrel R, Savy N, Molinier L, Pugnet G. Incremental Costs in Giant Cell Arteritis. Arthritis Care & Research. PMID 28973818 DOI: 10.1002/Acr.23429  0.525
2017 Sommet A, Lapeyre-Mestre M. Drug Use and Mortality in Parkinson Disease. Journal of the American Medical Directors Association. PMID 28866352 DOI: 10.1016/J.Jamda.2017.07.015  0.575
2017 Palmaro A, Gauthier M, Despas F, Lapeyre-Mestre M. Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients. Pharmacoepidemiology and Drug Safety. PMID 28745019 DOI: 10.1002/Pds.4266  0.357
2017 de Campaigno EP, Kebir I, Montastruc JL, Rueter M, Maret D, Lapeyre-Mestre M, Sallerin B, Despas F. Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase. Drug Safety. PMID 28744845 DOI: 10.1007/S40264-017-0575-5  0.37
2017 Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. Annals of Family Medicine. 15: 355-358. PMID 28694272 DOI: 10.1370/Afm.2098  0.649
2017 Casaurancq MC, Campaigno EP, Rueter M, Baricault B, Bourrel R, Lapeyre-Mestre M, Sommet A. [Outpatient consumption of antibiotics with a bacterial resistance risk in 2014 in France]. Therapie. PMID 28647106 DOI: 10.1016/J.Therap.2017.03.002  0.499
2017 Thu Trang D, Cool C, Laffon de Mazieres C, Lapeyre-Mestre M, Montastruc JL, Rascol O, Rolland Y, Sommet A. Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson Disease in Nursing Homes. Journal of the American Medical Directors Association. PMID 28623157 DOI: 10.1016/J.Jamda.2017.04.014  0.552
2017 Caillet C, Sichanh C, Assemat G, Malet-Martino M, Sommet A, Bagheri H, Sengxeu N, Mongkhonmath N, Mayxay M, Syhakhang L, Lapeyre-Mestre M, Newton PN, Roussin A. Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People's Democratic Republic. Drug Safety. PMID 28528487 DOI: 10.1007/S40264-017-0544-Z  0.57
2017 Jouanjus E, Raymond V, Lapeyre-Mestre M, Wolff V. What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review. Current Atherosclerosis Reports. 19: 26. PMID 28432636 DOI: 10.1016/J.Clinthera.2017.05.054  0.632
2017 Palmaro A, Gauthier M, Conte C, Grosclaude P, Despas F, Lapeyre-Mestre M. Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry. Medicine. 96: e6189. PMID 28328805 DOI: 10.1097/Md.0000000000006189  0.31
2017 Palmaro A, Boucherie Q, Dupouy J, Micallef J, Lapeyre-Mestre M. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies? Pharmacoepidemiology and Drug Safety. PMID 28266748 DOI: 10.1002/Pds.4193  0.662
2017 Gallini A, Coley N, Andrieu S, Lapeyre-Mestre M, Gardette V. Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007-2012. Fundamental & Clinical Pharmacology. PMID 28258589 DOI: 10.1111/Fcp.12281  0.687
2017 Ponté C, Pi C, Palmaro A, Jouanjus E, Lapeyre-Mestre M. Early Signal of Diverted Use of Tropicamide Eye Drops in France. British Journal of Clinical Pharmacology. PMID 28239898 DOI: 10.1111/Bcp.13272  0.655
2017 Jouanjus E, Mallaret M, Micallef J, Ponté C, Roussin A, Lapeyre-Mestre M. Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter". Drug Safety. 40: 183-185. PMID 28070741 DOI: 10.1007/S40264-016-0497-7  0.626
2017 Dupouy J, Lapeyre-Mestre M, Oustric S. Psychiatric disorders as predictors of long-term opioid therapy and the need for treating chronic pain correctly in patients with prior opioid substance use disorder: a commentary. Pain. 158: 6-7. PMID 27764036 DOI: 10.1097/J.Pain.0000000000000748  0.627
2017 Pugnet G, Lapeyre-Mestre M, Mounie M, Moulis G, Sailler L. AB0565 Insufficient influenza vaccination coverage in giant cell arteritis. a french population-based study Annals of the Rheumatic Diseases. 76: 1248-1248. DOI: 10.1136/Annrheumdis-2017-Eular.1814  0.544
2017 Delcourt N, Lafaurie M, Jouanjus E, Lapeyre-Mestre M, Franchitto N. Intoxications aiguës lors de l’usage détourné des médicaments antitussifs et antihistaminiques chez les adolescents et jeunes adultes : étude à partir des données du CAPTV de Toulouse Toxicologie Analytique Et Clinique. 29: S69. DOI: 10.1016/J.Toxac.2017.03.102  0.632
2017 Ponté C, Palmaro A, Jouanjus É, Lapeyre-Mestre M. Émergence d’un signal d’utilisation détournée de collyre à base de tropicamide en France : un exemple d’enquête d’addictovigilance Therapies. 72: 167-168. DOI: 10.1016/J.Therap.2016.11.049  0.666
2017 Dupui M, Jouanjus É, Lapeyre-Mestre M. Citations de benzodiazépines et apparentées sur les ordonnances suspectes enregistrées dans l’enquête Osiap Therapies. 72: 166. DOI: 10.1016/J.Therap.2016.11.046  0.66
2017 Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortalité associée aux périodes sous et hors traitement par buprénorphine Therapies. 72: 164. DOI: 10.1016/J.Therap.2016.11.041  0.662
2017 Lafaurie M, Delcourt N, Ponté C, Petiot D, Durrieu G, Jouanjus E, Lapeyre-Mestre M. Mésusage de médicaments antitussifs et antihistaminiques chez les jeunes dans la région Midi-Pyrénées Therapies. 72: 163. DOI: 10.1016/J.Therap.2016.11.039  0.659
2017 Jouanjus E, Raymond V, Lapeyre-Mestre M, Wolff V. Risque cardiovasculaire associé à l’utilisation de cannabis : une revue systématique de la littérature Therapies. 72: 160. DOI: 10.1016/J.Therap.2016.11.033  0.662
2017 Jouanjus E, Monpagens C, Petiot D, Molinier L, Lapeyre-Mestre M. Hospitalisations pour motifs cardiovasculaires de jeunes consommateurs de cannabis identifiés à partir de l’exploration des données du PMSI enregistrées au centre hospitalier universitaire de Toulouse Therapies. 72: 159-160. DOI: 10.1016/J.Therap.2016.11.031  0.664
2017 Ekstrand C, Baricault B, Linder M, Lafaurie M, Sailler L, Lapeyre-Mestre M, Kieler H, Bahmanyar S, Moulis G. Incidence des thromboses veineuses et artérielles et expositions aux médicaments cardiovasculaires chez les adultes atteints de PTI primaire incident et non-splénectomisés en Suède et en France. Études populationnelle à l’échelle des deux pays La Revue De MéDecine Interne. 38: A98-A99. DOI: 10.1016/J.Revmed.2017.10.402  0.316
2017 Lafaurie M, Baricault B, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risque de purpura thrombopénique immunologique post-vaccinal chez l’enfant. Case cross-over et self-controlled case series . Étude populationnelle en France La Revue De MéDecine Interne. 38: A56. DOI: 10.1016/J.Revmed.2017.10.330  0.56
2017 Piel-Julian M, Mahevas M, Comont T, Brun N, Dingremont C, Castel B, Lapeyre-Mestre M, Beyne-rauzy O, Adoue D, Godeau B, Moulis G. Seuil de numération plaquettaire et autres facteurs de risque hémorragique au diagnostic de thrombopénie immunologique de l’adulte La Revue De MéDecine Interne. 38: A55-A56. DOI: 10.1016/J.Revmed.2017.10.329  0.303
2017 Do M, Pugnet G, Moulis G, Guernec G, Lapeyre-Mestre M, Sailler L. Artérite à cellules géantes : risques d’évènements indésirables non cardiovasculaires et de cancer dans la cohorte APOGEE au cours des 36 mois suivant le diagnostic La Revue De MéDecine Interne. 38: A30. DOI: 10.1016/J.Revmed.2017.10.287  0.318
2017 Palmaro A, Patras de Campaigno E, Dupui M, Barricault B, Despas F, Lapeyre-Mestre M. Analyse de données longitudinales pour la production d’indicateurs automatisés sur les interactions médicamenteuses potentielles : application aux bases de données de l’Assurance maladie Revue D'éPidéMiologie Et De Santé Publique. 65: S12-S13. DOI: 10.1016/J.Respe.2017.01.024  0.315
2017 Jouanjus E, Lafaurie M, Pochard L, Lotiron C, Molinier L, Lapeyre-Mestre M. Searching Hospital Database for Detecting the Serious Consequences Related to Use of Drugs With an Abuse Potential Clinical Therapeutics. 39: e91. DOI: 10.1016/J.Clinthera.2017.05.284  0.691
2017 Conte C, Laurent G, Despas F, Lapeyre-Mestre M. Patterns and Consequences of Psychotropic Drug use in Lymphomas: A Retrospective Cohort Study in a French Claims Database Clinical Therapeutics. 39: e71. DOI: 10.1016/J.Clinthera.2017.05.218  0.378
2017 Dupui M, Jouanjus E, Lapeyre-Mestre M. Identifying Prescription Drugs Potentially Misused: Results of the Osiap Survey Clinical Therapeutics. 39: e69-e70. DOI: 10.1016/J.Clinthera.2017.05.212  0.702
2017 Dupui M, Jouanjus E, Lapeyre-Mestre M. Patterns of Use and Diversion of Benzodiazepines and Related Substances in France: Results of the Osiap Survey Clinical Therapeutics. 39: e68-e69. DOI: 10.1016/J.Clinthera.2017.05.209  0.647
2017 Driot D, Palmaro A, Dupouy J, Oustric S, Jouanjus E, Lapeyre-Mestre M. Patterns of Use of Pregabalin and Gabapentin in France: A Cohort Study of New Users on a French Representative Sample Clinical Therapeutics. 39: e52-e53. DOI: 10.1016/J.Clinthera.2017.05.163  0.749
2017 de Campaigno EP, Kebir I, Lapeyre-Mestre M, Montastruc J, Despas F. Drug-Induced Dental Caries, Lessons from a Disproportionality Analysis in Vigibase®: Beware of Bisphosphonates, Atropinic, Immunosuppressant and Hyperglycaemic Drugs Clinical Therapeutics. 39: e41. DOI: 10.1016/J.Clinthera.2017.05.129  0.371
2017 Palmaro A, Patras de Campaigno E, Dupui M, Baricault B, Dupouy J, Despas F, Lapeyre-Mestre M. Identifying Potential Drug–Drug Interactions In The French Health Insurance Databases: Application In Multiple Myeloma Patients Clinical Therapeutics. 39: e33. DOI: 10.1016/J.Clinthera.2017.05.103  0.628
2017 Lapeyre-Mestre M, Chauvin E, Jouanjus E, Pauly V, Lafaurie M, Roussin A. Cannabis Exposure in Young Children: Increasing Rate of Hospitalisation in France in The Recent Years Clinical Therapeutics. 39: e13. DOI: 10.1016/J.Clinthera.2017.05.041  0.617
2017 Baricault B, Palmaro A, Lapeyre-Mestre M. Mortality Related to Benzodiazepines or Other Psychotropic Drugs in Patients with Cancer Clinical Therapeutics. 39: e12-e13. DOI: 10.1016/J.Clinthera.2017.05.040  0.326
2017 Casaurancq M, Rueter M, Baricault B, de Campaigno EP, Araujo M, Lapeyre-Mestre M, Sommet A. Outpatient Antibiotic Prescriptions with High Risk of Bacterial Resistance in France: A National Healthcare Insurance Database Analysis Clinical Therapeutics. 39: e12. DOI: 10.1016/J.Clinthera.2017.05.039  0.517
2016 Montastruc JL, Durriel G, Lacroix I, Lapeyre-Mestre M, Damase-Michel C, Bagheri H, Sommet A. Which pharmacovigilance for vaccines? Bulletin De L'Academie Nationale De Medecine. 200: 241-250. PMID 29898320 DOI: 10.1016/S0001-4079(19)30755-1  0.564
2016 Récoché I, Lebaudy C, Cool C, Sourdet S, Piau A, Lapeyre-Mestre M, Vellas B, Cestac P. Potentially inappropriate prescribing in a population of frail elderly people. International Journal of Clinical Pharmacy. PMID 27942948 DOI: 10.1007/S11096-016-0406-2  0.389
2016 Lapeyre-Mestre M. A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia. Drugs & Aging. 33: 865-888. PMID 27812994 DOI: 10.1007/S40266-016-0414-X  0.349
2016 Récoché I, Rousseau V, Bourrel R, Lapeyre-Mestre M, Chebane L, Despas F, Montastruc JL, Bondon-Guitton E. Drug-drug interactions with imatinib: An observational study. Medicine. 95: e5076. PMID 27749579 DOI: 10.1097/Md.0000000000005076  0.393
2016 Nguyen TT, Pariente A, Montastruc JL, Lapeyre-Mestre M, Rousseau V, Rascol O, Bégaud B, Montastruc F. An original pharmacoepidemiologic - pharmacodynamic method: application to antipsychotic-induced movement disorders. British Journal of Clinical Pharmacology. PMID 27687785 DOI: 10.1111/Bcp.13145  0.329
2016 Pugnet G, Sailler L, Fournier JP, Bourrel R, Montastruc JL, Lapeyre-Mestre M. Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study. The Journal of Rheumatology. 43: 2162-2170. PMID 27585686 DOI: 10.3899/Jrheum.151500  0.55
2016 Driot D, Chicoulaa B, Jouanjus E, Dupouy J, Oustric S, Lapeyre-Mestre M. Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history. Therapie. 71: 575-578. PMID 27473599 DOI: 10.1016/J.Therap.2016.04.006  0.759
2016 Conte C, Rueter M, Laurent G, Bourrel R, Lapeyre-Mestre M, Despas F. Psychotropic drug initiation during the first diagnosis and the active treatment phase of B cell non-Hodgkin's lymphoma: a cohort study of the French national health insurance database. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 24: 4791-9. PMID 27435321 DOI: 10.1007/S00520-016-3331-Y  0.335
2016 Palmaro A, Moulis G, Despas F, Dupouy J, Lapeyre-Mestre M. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies. Fundamental & Clinical Pharmacology. 30: 616-624. PMID 27351637 DOI: 10.1111/Fcp.12214  0.692
2016 Bossard JB, Ponté C, Dupouy J, Lapeyre-Mestre M, Jouanjus E. Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database. Clinical Drug Investigation. PMID 27300651 DOI: 10.1007/S40261-016-0421-Z  0.764
2016 Breu-Dejean N, Driot D, Dupouy J, Lapeyre-Mestre M, Rostaing L. Efficacy of Psychoeducational Intervention on Allograft Function in Kidney Transplant Patients: 10-Year Results of a Prospective Randomized Study. Experimental and Clinical Transplantation : Official Journal of the Middle East Society For Organ Transplantation. 14: 38-44. PMID 26862823  0.575
2016 Montastruc J, Durrieu G, Lacroix I, Lapeyre-Mestre M, Damase-Michel C, Bagheri H, Sommet A. Quelle PharmacoVigilance pour les vaccins ? Bulletin De L'AcadéMie Nationale De MéDecine. 200: 241-250. DOI: 10.1016/s0001-4079(19)30755-1  0.458
2016 Moulis G, Pugnet G, Costedoat-Chalumeau N, Mathian A, Leroux G, Boutemy J, Bouillet L, Berthier S, Piette J, Arlet P, Lapeyre-Mestre M, Sailler L. Efficacité et sécurité des biothérapies dans la polychondrite atrophiante. Résultats de l’observatoire BIOPCA La Revue De MéDecine Interne. 37: A82. DOI: 10.1016/J.Revmed.2016.10.041  0.309
2016 Mounié M, Costa N, Savy N, Molinier L, Bourel R, Lapeyre-Mestre M, Sailler L, Pugnet G. Évaluation du coût de prise en charge de l’artérite à cellules géantes avec ou sans pseudopolyarthrite rhizomélique La Revue De MéDecine Interne. 37: A54. DOI: 10.1016/J.Revmed.2016.04.264  0.584
2016 Mounié M, Costa N, Gauthier M, Palmaro A, Delpierre C, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Molinier L. Évaluation du coût de prise en charge des patients atteints de leucémie myéloïde chronique en Midi-Pyrénées Revue D'éPidéMiologie Et De Santé Publique. 64: S259-S260. DOI: 10.1016/J.Respe.2016.06.322  0.303
2016 Verga-Gérard A, Mathoulin-Pélissier S, Chauvin F, Huiart L, Katsahian S, Nacher M, Alberti C, Binquet C, Fourrier-Réglat A, Bellisant E, Giraudeau B, Lapeyre-Mestre M, Tubach F, Guillemin F. RECaP : réseau national de recherche en épidémiologie clinique et en santé publique Revue D'éPidéMiologie Et De Santé Publique. 64: S160-S161. DOI: 10.1016/J.Respe.2016.03.107  0.302
2016 Palmaro A, Gauthier M, Despas F, Lapeyre-Mestre M. Reconstituer les lignes de traitement reçues en onco-hématologie à partir des données du Sniiram et du PMSI : application à l’étude des cycles de chimiothérapie dans le myélome multiple Revue D'éPidéMiologie Et De Santé Publique. 64: S11. DOI: 10.1016/J.Respe.2016.01.040  0.309
2016 Boucherie Q, Dupouy J, Micallef J, Lapeyre-Mestre M, Palmaro A. Périodes d’exposition inobservables au cours des séjours hospitaliers en PMSI MCO : quel impact pour les études pharmacoépidémiologiques ? Revue D'éPidéMiologie Et De Santé Publique. 64: S29-S30. DOI: 10.1016/J.Respe.2016.01.004  0.658
2016 Laconi S, Cailhol L, Pourcel L, Thalamas C, Lapeyre-Mestre M, Chabrol H. Dépistage des troubles de la personnalité avec la version française du Personality Diagnostic Questionnaire-4+ dans une population psychiatrique : une étude préliminaire Annales MéDico-Psychologiques, Revue Psychiatrique. 174: 39-44. DOI: 10.1016/J.Amp.2014.10.022  0.309
2015 Montastruc JL, Sommet A, Montastruc F, Moulis G, Bagheri H, Damase-michel C, Lapeyre-mestre M. [Pharmacoepidemiology: definition, methods and applications]. Bulletin De L'Academie Nationale De Medecine. 199: 263-73; discussion 2. PMID 27476308 DOI: 10.1016/S0001-4079(19)30970-7  0.59
2015 Palmaro A, Dupouy J, Lapeyre-Mestre M. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1566-77. PMID 26256008 DOI: 10.1016/J.Euroneuro.2015.07.006  0.651
2015 Gallini A, Gardette V, Lapeyre-Mestre M, De Souto Barreto P, Vellas B, Andrieu S, Rolland Y. Dementia diagnosis and influenza vaccination in French nursing home residents Journal of the American Geriatrics Society. 63: 1256-1258. PMID 26096405 DOI: 10.1111/Jgs.13515  0.669
2015 Lapeyre-Mestre M, Dupui M. Drug abuse monitoring: which pharmacoepidemiological resources at the European level? Therapie. 70: 147-65. PMID 25858571 DOI: 10.2515/Therapie/2015010  0.391
2015 Micallef J, Lapeyre-Mestre M. [Addictovigilance: the pharmacological challenge of assessment and prevention of risky substances]. Therapie. 70: 111. PMID 25858565 DOI: 10.2515/Therapie/2015017  0.311
2015 Moulis F, Moulis G, Balardy L, Gérard S, Montastruc F, Sourdet S, Rougé-Bugat ME, Lapeyre-Mestre M, Montastruc JL, Rolland Y, Vellas B. Exposure to atropinic drugs and frailty status. Journal of the American Medical Directors Association. 16: 253-7. PMID 25548029 DOI: 10.1016/J.Jamda.2014.11.017  0.378
2015 Roulet L, Ballereau F, Lapeyre-Mestre M, Joris-Frasseren M, Asseray N. [Developing a terminology in the French language for clinical practice and research in drug safety]. Therapie. 70: 283-92. PMID 25534521 DOI: 10.2515/Therapie/2014215  0.388
2015 Pugnet G, Sailler L, Bourrel R, Montastruc JL, Lapeyre-Mestre M. Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study. The Journal of Rheumatology. 42: 316-22. PMID 25512477 DOI: 10.3899/Jrheum.140906  0.549
2015 Palmaro A, Bissuel R, Renaud N, Durrieu G, Escourrou B, Oustric S, Montastruc JL, Lapeyre-Mestre M. Off-label prescribing in pediatric outpatients. Pediatrics. 135: 49-58. PMID 25511119 DOI: 10.1542/Peds.2014-0764  0.345
2015 Lapeyre-Mestre M, Dupui M. Système de surveillance en addictovigilance : quelles données pharmacoépidémiologiques à l'échelle de l'Europe ? Therapies. 70: 147-156. DOI: 10.2515/Therapie/2015006  0.308
2015 Moulis G, Comont T, Germain J, Brun N, Dingremont C, Castel B, Arista S, Madaule S, Montané de la Roque P, Prudhomme L, Sailler L, Balardy L, Borel C, Sire S, Martin-Blondel G, ... ... Lapeyre-Mestre M, et al. Clinical Epidemiology and First-Line Treatment in Immune Thrombocytopenia Adults. Results of the Carmen Prospective Cohort Blood. 126: 3473-3473. DOI: 10.1182/Blood.V126.23.3473.3473  0.309
2015 Mezaache S, Comont T, Germain J, Montastruc F, Brun N, Dingremont C, Dingremont C, Castel B, Arista S, Madaule S, Montané de la Roque P, Prudhomme L, Sailler L, Balardy L, Borel C, ... ... Lapeyre-Mestre M, et al. Incidence of Adverse Drug Reactions Related to Immune Thrombocytopenia Drugs. A Prospective Cohort Study Blood. 126: 1056-1056. DOI: 10.1182/Blood.V126.23.1056.1056  0.41
2015 Pugnet G, Costa N, Bouscaren N, Bourrel R, Lapeyre-Mestre M, Sailler L, Molinier L. THU0283 Incremental Costs of Giant Cell Arteritis in France Annals of the Rheumatic Diseases. 74: 298.3-298. DOI: 10.1136/Annrheumdis-2015-Eular.4187  0.555
2015 Moulis G, Lapeyre-Mestre M, Palmaro A, Sailler L. Infections graves et non graves chez les patients non splénectomisés traités pour une thrombopénie immunologique persistante ou chronique : rôles des traitements et effet des vaccins antipneumococcique et antigrippal. Étude dans la cohorte FAITH La Revue De MéDecine Interne. 36: A73. DOI: 10.1016/J.Revmed.2015.10.296  0.317
2015 Moulis G, Sailler L, Lapeyre-Mestre M. Fonction de risque d’infection grave des corticoïdes dans la thrombopénie immunologique primaire persistante ou chronique. Étude cas-témoins nichée dans la cohorte FAITH La Revue De MéDecine Interne. 36: A53. DOI: 10.1016/J.Revmed.2015.03.287  0.313
2015 Moulis G, Comont T, Brun N, Dingremont C, Castel B, Arista S, Madaule S, Montané De La Roque P, Prudhomme L, Lapeyre-Mestre M, Beyne-rauzy O, Adoue D. Prescription et rentabilité diagnostique du bilan paraclinique au diagnostic de thrombopénie immunologique. Résultats du registre CARMEN La Revue De MéDecine Interne. 36: A51-A52. DOI: 10.1016/J.Revmed.2015.03.285  0.314
2015 Palmaro A, Despas F, Lapeyre-Mestre M. Thomboprophylaxis In Multiple Myeloma Patients Treated With Lenalidomide or Thalidomide Clinical Therapeutics. 37: e65. DOI: 10.1016/J.Clinthera.2015.05.195  0.317
2015 Couderc S, Bourrel R, Paul C, Montastruc J, Lapeyre-Mestre M, Sommet A. Infectious risk of biological drugs versus conventional systemic treatments in moderate to severe psoriasis Clinical Therapeutics. 37: e4. DOI: 10.1016/J.Clinthera.2015.05.020  0.611
2014 Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc JL, Sailler L. French health insurance databases: What interest for medical research? La Revue De Medecine Interne. 36: 411-7. PMID 25547954 DOI: 10.1016/J.Revmed.2014.11.009  0.589
2014 Pauly V, Lapeyre-Mestre M, Braunstein D, Rueter M, Thirion X, Jouanjus E, Micallef J. Detection of signals of abuse and dependence applying disproportionality analysis. European Journal of Clinical Pharmacology. 71: 229-36. PMID 25407613 DOI: 10.1007/S00228-014-1783-X  0.688
2014 Cool C, Cestac P, Laborde C, Lebaudy C, Rouch L, Lepage B, Vellas B, Barreto Pde S, Rolland Y, Lapeyre-Mestre M. Potentially inappropriate drug prescribing and associated factors in nursing homes. Journal of the American Medical Directors Association. 15: 850.e1-9. PMID 25284165 DOI: 10.1016/J.Jamda.2014.08.003  0.341
2014 Moulis G, Bagheri H, Sailler L, Jonville-Bera AP, Weber E, Guy C, Petitpain N, Laroche ML, Favrelière S, Béné J, Baldin B, Villeval-Federici L, Tebacher-Alt M, Bres V, Veyrac G, ... ... Lapeyre-Mestre M, et al. Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment. European Journal of Internal Medicine. 25: 777-80. PMID 25242516 DOI: 10.1016/J.Ejim.2014.09.006  0.322
2014 Moulis G, Sommet A, Lapeyre-Mestre M, Montastruc JL. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. Rheumatology (Oxford, England). 53: 1864-71. PMID 24899660 DOI: 10.1093/Rheumatology/Keu214  0.54
2014 Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL. More on the "triple Whammy": Antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury-a case/non-case study in the French pharmacovigilance database Renal Failure. 36: 1166-1168. PMID 24826803 DOI: 10.3109/0886022X.2014.917943  0.607
2014 Jouanjus E, Lapeyre-Mestre M, Micallef J. Cannabis use: signal of increasing risk of serious cardiovascular disorders. Journal of the American Heart Association. 3: e000638. PMID 24760961 DOI: 10.1161/Jaha.113.000638  0.614
2014 Fuzier R, Serres I, Bourrel R, Palmaro A, Montastruc JL, Lapeyre-Mestre M. Analgesic drug consumption increases after knee arthroplasty: a pharmacoepidemiological study investigating postoperative pain. Pain. 155: 1339-45. PMID 24727347 DOI: 10.1016/J.Pain.2014.04.010  0.318
2014 Lapeyre-Mestre M, Gony M, Carvajal A, Macias D, Conforti A, D'Incau P, Heerdink R, Van der Stichele R, Bergman U. A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions. European Addiction Research. 20: 174-82. PMID 24458222 DOI: 10.1159/000356812  0.31
2014 Dupouy J, Mémier V, Catala H, Lavit M, Oustric S, Lapeyre-Mestre M. Does urine drug abuse screening help for managing patients? A systematic review. Drug and Alcohol Dependence. 136: 11-20. PMID 24417964 DOI: 10.1016/J.Drugalcdep.2013.12.009  0.667
2014 Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S. A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study. Cns Drugs. 28: 157-70. PMID 24408842 DOI: 10.1007/S40263-013-0133-3  0.737
2014 Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. Plos One. 9: e82222. PMID 24404128 DOI: 10.1371/Journal.Pone.0082222  0.506
2014 Dupouy J, Fournier JP, Jouanjus E, Palmaro A, Poutrain JC, Oustric S, Lapeyre-Mestre M. Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns-A cohort study European Neuropsychopharmacology. 24: 192-199. PMID 24139234 DOI: 10.1016/J.Euroneuro.2013.09.008  0.762
2014 Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V. Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 95-104. PMID 24126116 DOI: 10.1016/J.Euroneuro.2013.09.003  0.726
2014 Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Derumeaux H, Adoue D. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity. American Journal of Hematology. 89: 41-6. PMID 24038066 DOI: 10.1002/Ajh.23580  0.532
2014 Bounes V, Jouanjus E, Roussin A, Lapeyre-Mestre M. Acute pain management for patients under opioid maintenance treatment: what physicians do in emergency departments? European Journal of Emergency Medicine : Official Journal of the European Society For Emergency Medicine. 21: 73-6. PMID 23872995 DOI: 10.1097/Mej.0B013E328363C9E0  0.732
2014 D'Incau P, Lapeyre-Mestre M, Carvajal A, Donati M, Salado I, Rodriguez L, Sáinz M, Escudero A, Conforti A. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain. Fundamental & Clinical Pharmacology. 28: 342-8. PMID 23617454 DOI: 10.1111/Fcp.12032  0.33
2014 Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database. Fundamental & Clinical Pharmacology. 28: 230-5. PMID 23190210 DOI: 10.1111/Fcp.12014  0.569
2014 N'Guyen TTL, Lapeyre-Mestre M, Montastruc F, Montastruc J, Moulis G. Signal for a Different Risk of Thrombosis Between Eltrombopag and Romiplostim Blood. 124: 2170-2170. DOI: 10.1182/Blood.V124.21.2170.2170  0.308
2014 Cool C, Lebaudy C, Rouch L, Rolland Y, Lapeyre-Mestre M, Cestac P. CP-042 Inappropriate drug prescriptions and associated factors in Nursing Homes European Journal of Hospital Pharmacy. 21: A17.2-A17. DOI: 10.1136/Ejhpharm-2013-000436.41  0.389
2014 Moulis G, Lapeyre-Mestre M, Godeau B, Sailler L. L’exposition aux vaccins recommandés est insuffisante chez les patients splénectomisés pour thrombopénie immunologique primaire : résultats de l’étude FAITH (French Adult Immune Thrombocytopenia : a pHarmacoepidemiological study) La Revue De MéDecine Interne. 35: A88-A89. DOI: 10.1016/J.Revmed.2014.10.141  0.314
2014 Moulis G, Lapeyre-Mestre M, Montastruc J, Godeau B, Sailler L. Exposition aux traitements d’épargne cortisonique chez les patients adultes atteints de thrombopénie immunologique primaire avant la phase de chronicité de la maladie en France à l’ère des agonistes du récepteur de la thrombopoiétine La Revue De MéDecine Interne. 35: A65-A66. DOI: 10.1016/J.Revmed.2014.10.103  0.316
2014 N’guyen T, Lapeyre-Mestre M, Montastruc J, Montastruc F, Moulis G. Signal de pharmacovigilance pour un risque différent de thrombose entre l’eltrombopag et le romiplostim : étude de disproportionnalité dans la base de pharmacovigilance de l’Organisation mondiale pour la santé La Revue De MéDecine Interne. 35: A64-A65. DOI: 10.1016/J.Revmed.2014.10.101  0.302
2014 Bouscaren N, Pugnet G, Costa N, Bourel R, Lapeyre-Mestre M, Sailler L, Molinier L. Étude « cost of illness » de la maladie de Horton en Midi-Pyrénées La Revue De MéDecine Interne. 35: A44-A45. DOI: 10.1016/J.Revmed.2014.10.066  0.311
2014 Moulis G, Lapeyre-Mestre M, Arnaud L, Adoue D, Sailler L. Incidence de la thrombopénie immunologique en France : un gradient nord-sud La Revue De MéDecine Interne. 35: A80-A81. DOI: 10.1016/J.Revmed.2014.03.105  0.303
2014 Gallini A, Gardette V, Lapeyre-Mestre M, Andrieu S. Recours à la vaccination contre la grippe saisonnière chez les personnes âgées : effet de la démence Revue D'éPidéMiologie Et De Santé Publique. 62: S82-S83. DOI: 10.1016/J.Respe.2014.01.037  0.699
2014 Micallef J, Lapeyre-Mestre M, Revah-Levy A, Castot A, Jouve E, Dreno B, Chosidow O. Vers une meilleure prise en charge des patients sous isotrétinoïne ? Étude d’acceptabilité d’une conduite pratique de surveillance des troubles dépressifs en consultation de dermatologie pour acné sévère Annales De Dermatologie Et De VéNéRéOlogie. 141: S248-S249. DOI: 10.1016/J.Annder.2014.09.065  0.317
2013 Lapeyre-Mestre M, Sapède C, Moore N, Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, et al. [Not Available]. Therapie. 68: 241-6. PMID 27392726 DOI: 10.2515/Therapie/2013037  0.308
2013 Bounes V, Palmaro A, Lapeyre-Mestre M, Roussin A. Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment. Pain Physician. 16: E739-47. PMID 24284855  0.5
2013 Le Moigne M, Sommet A, Lapeyre-Mestre M, Bourrel R, Molinier L, Paul C, Montastruc JL. Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database. Journal of the European Academy of Dermatology and Venereology : Jeadv. 28: 1235-44. PMID 24236509 DOI: 10.1111/Jdv.12318  0.577
2013 Roussin A, Bouyssi A, Pouché L, Pourcel L, Lapeyre-Mestre M. Misuse and dependence on non-prescription codeine analgesics or sedative H1 antihistamines by adults: a cross-sectional investigation in France. Plos One. 8: e76499. PMID 24098516 DOI: 10.1371/Journal.Pone.0076499  0.349
2013 Lapeyre-Mestre M, Sapède C, Moore N, Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, et al. Pharmacoepidemiology studies: what levels of evidence and how can they be reached? ThéRapie. 68: 241-52. PMID 23981262 DOI: 10.2515/Therapie/2013038  0.362
2013 Dupouy J, Moulis G, Tubery M, Ecoiffier M, Sommet A, Poutrain JC, Arlet P, Lapeyre-Mestre M. Which adverse events are related to health care during hospitalization in elderly inpatients? International Journal of Medical Sciences. 10: 1224-30. PMID 23935400 DOI: 10.7150/Ijms.6640  0.714
2013 Dupouy J, Bez J, Barsony J, Oustric S, Lapeyre-Mestre M. [Opiate substitution treatment's cycles in a five-year followed-up cohort in ambulatory practice]. Therapie. 68: 155-61. PMID 23886460 DOI: 10.2515/Therapie/2013022  0.626
2013 Durrieu G, Mazau B, Jégu J, Lapeyre-Mestre M, Delord JP, Montastruc JL. Drugs and cancer: an analysis of the French Pharmacovigilance Database. Therapie. 68: 149-54. PMID 23886459 DOI: 10.2515/Therapie/2013023  0.343
2013 Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! European Journal of Clinical Pharmacology. 69: 1589-97. PMID 23588564 DOI: 10.1007/S00228-013-1506-8  0.718
2013 Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C. Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease. Drugs & Aging. 30: 439-45. PMID 23512718 DOI: 10.1007/S40266-013-0070-3  0.694
2013 Moulis G, Sommet A, Lapeyre-Mestre M. Mortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al. Arthritis and Rheumatism. 65: 1670-1. PMID 23508973 DOI: 10.1002/art.37931  0.47
2013 Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Adoue D. Prevalence of pneumococcal vaccination in adult immune thrombocytopenia patients exposed to rituximab or to splenectomy. European Journal of Haematology. 90: 438-9. PMID 23444912 DOI: 10.1111/Ejh.12091  0.509
2013 Peyriere H, Eiden C, Micallef J, Lapeyre-Mestre M, Faillie JL, Blayac JP. Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France. European Addiction Research. 19: 235-44. PMID 23428846 DOI: 10.1159/000346179  0.3
2013 Nordmann S, Pradel V, Lapeyre-Mestre M, Frauger E, Pauly V, Thirion X, Mallaret M, Jouanjus E, Micallef J. Doctor shopping reveals geographical variations in opioid abuse. Pain Physician. 16: 89-100. PMID 23340537  0.636
2013 Dupouy J, Dassieu L, Bourrel R, Poutrain JC, Bismuth S, Oustric S, Lapeyre-Mestre M. Effectiveness of drug tests in outpatients starting opioid substitution therapy. Journal of Substance Abuse Treatment. 44: 515-21. PMID 23337248 DOI: 10.1016/J.Jsat.2012.11.006  0.68
2013 Fuzier R, Serres I, Guitton E, Lapeyre-Mestre M, Montastruc JL. Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database. Drug Safety. 36: 55-62. PMID 23315296 DOI: 10.1007/S40264-012-0006-6  0.797
2013 Danton AC, Montastruc F, Sommet A, Durrieu G, Bagheri H, Bondon-Guitton E, Lapeyre-Mestre M, Montastruc JL. Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France. European Journal of Clinical Pharmacology. 69: 885-8. PMID 22996074 DOI: 10.1007/S00228-012-1394-3  0.599
2013 Lapeyre-Mestre M, Grolleau S, Montastruc JL. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Fundamental & Clinical Pharmacology. 27: 223-30. PMID 21929527 DOI: 10.1111/J.1472-8206.2011.00991.X  0.322
2013 Moulis G, Sommet A, Lapeyre-Mestre M, Montastruc J. Le risque de lupus induit par anti-TNF alpha est-il le même selon les différents anti-TNF-alpha ? Une étude cas/non-cas dans la base nationale française de pharmacovigilance La Revue De MéDecine Interne. 34: A72. DOI: 10.1016/J.Revmed.2013.10.110  0.52
2013 Moulis G, Palmaro A, Adoue D, Lapeyre-Mestre M, Sailler L. Incidence de la thrombopénie immunologique en France. Résultats à partir de la cohorte FAITH La Revue De MéDecine Interne. 34: A66. DOI: 10.1016/J.Revmed.2013.10.099  0.311
2013 Le Moigne M, Sommet A, Lapeyre-Mestre M, Bourrel R, Molinier L, Montastruc J, Paul C. Impact économique des biothérapies dans le psoriasis en comparaison aux traitements systémiques classiques: analyse des données de l’Assurance maladie Annales De Dermatologie Et De VéNéRéOlogie. 140: S428-S429. DOI: 10.1016/J.Annder.2013.09.144  0.557
2012 Sommet A, Ferrières N, Jaoul V, Cadieux L, Soulat JM, Lapeyre-Mestre M, Montastruc JL. Use of drugs, tobacco, alcohol and illicit substances in a French student population. Therapie. 67: 429-35. PMID 23241252 DOI: 10.2515/Therapie/2012056  0.55
2012 Moulis G, Sommet A, Béné J, Montastruc F, Sailler L, Montastruc JL, Lapeyre-Mestre M. Cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses. Plos One. 7: e48991. PMID 23155441 DOI: 10.1371/Journal.Pone.0048991  0.552
2012 Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc JL, Vellas B, Andrieu S. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity. Current Alzheimer Research. 9: 1106-16. PMID 22950915 DOI: 10.2174/156720512803569037  0.708
2012 Jouanjus E, Pourcel L, Saivin S, Molinier L, Lapeyre-Mestre M. Use of multiple sources and capture-recapture method to estimate the frequency of hospitalizations related to drug abuse. Pharmacoepidemiology and Drug Safety. 21: 733-741. PMID 22550023 DOI: 10.1002/Pds.3280  0.703
2012 Fournier JP, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, Montastruc JL. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. European Journal of Clinical Pharmacology. 68: 1533-40. PMID 22527348 DOI: 10.1007/S00228-012-1283-9  0.576
2012 Fournier JP, Lapeyre-Mestre M, Sommet A, Dupouy J, Poutrain JC, Montastruc JL. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study. Plos One. 7: e34187. PMID 22479557 DOI: 10.1371/Journal.Pone.0034187  0.75
2012 Pauly V, Pradel V, Pourcel L, Nordmann S, Frauger E, Lapeyre-Mestre M, Micallef J, Thirion X. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France. Drug and Alcohol Dependence. 126: 13-20. PMID 22475815 DOI: 10.1016/J.Drugalcdep.2012.03.009  0.339
2012 Dupouy J, Bismuth S, Oustric S, Lapeyre-Mestre M. On-site drugs of abuse urinary screening tests for the management of opiate-addicted patients: a survey among French general practitioners. European Addiction Research. 18: 175-83. PMID 22440979 DOI: 10.1159/000336540  0.671
2012 Moulis G, Sommet A, Durrieu G, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database. British Journal of Clinical Pharmacology. 74: 201-4. PMID 22257367 DOI: 10.1111/J.1365-2125.2012.04185.X  0.59
2012 Sommet A, Durrieu G, Lapeyre-Mestre M, Montastruc JL. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006. Pharmacoepidemiology and Drug Safety. 21: 285-8. PMID 22162094 DOI: 10.1002/Pds.2307  0.554
2012 Montastruc F, Sommet A, Bondon-Guitton E, Durrieu G, Bui E, Bagheri H, Lapeyre-Mestre M, Schmitt L, Montastruc JL. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. European Journal of Clinical Pharmacology. 68: 767-75. PMID 22116460 DOI: 10.1007/S00228-011-1156-7  0.601
2012 Moulis G, Sommet A, Sailler L, Lapeyre-Mestre M, Montastruc JL. Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database. Platelets. 23: 490-4. PMID 22098130 DOI: 10.3109/09537104.2011.633179  0.599
2012 Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Montastruc JL. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study. Pharmacoepidemiology and Drug Safety. 21: 314-9. PMID 21953992 DOI: 10.1002/Pds.2253  0.534
2012 Lapeyre-Mestre M, Desboeuf K, Aptel I, Chale JJ, Montastruc JL. A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists. Clinical Drug Investigation. 16: 53-61. PMID 18370518 DOI: 10.2165/00044011-199816010-00007  0.373
2012 Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Recher C, Alric L, Arlet P, Adoue D. Incidence des complications locales post-chirurgicales de la splénectomie pour purpura thrombopénique immunologique primaire de l’adulte : étude monocentrique de 62 patients consécutifs La Revue De MéDecine Interne. 33: A102. DOI: 10.1016/J.Revmed.2012.10.154  0.555
2012 Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Recher C, Alric L, Arlet P, Adoue D. Prophylaxie infectieuse chez les patients adultes exposés au rituximab ou à la splénectomie pour purpura thrombopénique immunologique primaire La Revue De MéDecine Interne. 33: A101-A102. DOI: 10.1016/J.Revmed.2012.10.153  0.55
2012 Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Recher C, Alric L, Arlet P, Adoue D. Comparaison de la splénectomie et du rituximab dans la thrombopénie immunologique primaire de l’adulte : étude dans une cohorte monocentrique de 105 patients La Revue De MéDecine Interne. 33: A57. DOI: 10.1016/J.Revmed.2012.10.067  0.563
2012 Niezborala M, Boeuf-Cazou O, Lapeyre-Mestre M, Montastruc J. Profil de consommation de substances psychoactives dans le milieu du travail : résultats de l’enquête Mode de Vie et Travail Archives Des Maladies Professionnelles Et De L'Environnement. 73: 492. DOI: 10.1016/J.Admp.2012.03.272  0.773
2011 Dupouy J, Poutrain JC, Lapeyre-Mestre M. [Naltrexone and opiate substitutive treatment]. Therapie. 66: 549-52. PMID 22691393 DOI: 10.2515/Therapie/2011072  0.669
2011 Roulet L, Asseray N, Mottier ML, Chiffoleau A, Potel G, Lapeyre-Mestre M, Ballereau F. [Grapefruit consumption and food-drug interaction hazard]. Therapie. 66: 421-9. PMID 22031686 DOI: 10.2515/Therapie/2011051  0.338
2011 Pauly V, Frauger E, Pradel V, Nordmann S, Pourcel L, Natali F, Sciortino V, Lapeyre-Mestre M, Micallef J, Thirion X. Monitoring of benzodiazepine diversion using a multi-indicator approach. International Clinical Psychopharmacology. 26: 268-77. PMID 21829107 DOI: 10.1097/Yic.0B013E32834967E5  0.349
2011 Crespin S, Bourrel R, Hurault-Delarue C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Drug prescribing before and during pregnancy in south west France: a retrolective study. Drug Safety. 34: 595-604. PMID 21663335 DOI: 10.2165/11589170-000000000-00000  0.341
2011 Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. British Journal of Clinical Pharmacology. 72: 905-8. PMID 21658092 DOI: 10.1111/J.1365-2125.2011.04037.X  0.6
2011 Rouve N, Bagheri H, Telmon N, Pathak A, Franchitto N, Schmitt L, Rougé D, Lapeyre-Mestre M, Montastruc JL. Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database. European Journal of Clinical Pharmacology. 67: 1189-98. PMID 21655992 DOI: 10.1007/S00228-011-1067-7  0.385
2011 Bœuf-Cazou O, Lapeyre-Mestre M, Niezborala M, Montastruc JL. [Profile of psychoactive substances consumption in workplace]. Therapie. 66: 155-65. PMID 21635864 DOI: 10.2515/Therapie/2011021  0.77
2011 Berthet S, Olivier P, Montastruc JL, Lapeyre-Mestre M. Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database. Bmc Clinical Pharmacology. 11: 5. PMID 21609444 DOI: 10.1186/1472-6904-11-5  0.379
2011 Boeuf-Cazou O, Bongue B, Ansiau D, Marquié JC, Lapeyre-Mestre M. Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. European Journal of Clinical Pharmacology. 67: 1045-52. PMID 21494764 DOI: 10.1007/S00228-011-1047-Y  0.761
2011 Bismuth S, Leng EL, Oustric S, Montastruc JL, Lapeyre-Mestre M. [Which analgesic after dextropropoxyphene withdrawal? A survey in a sample of general practitioners in southwest of France]. Therapie. 66: 25-8. PMID 21466774 DOI: 10.2515/Therapie/2011004  0.333
2011 Jegu J, Gallini A, Soler P, Montastruc JL, Lapeyre-Mestre M. Slow-release oral morphine for opioid maintenance treatment: a systematic review. British Journal of Clinical Pharmacology. 71: 832-43. PMID 21265874 DOI: 10.1111/J.1365-2125.2011.03923.X  0.313
2011 Jouanjus E, Leymarie F, Tubery M, Lapeyre-Mestre M. Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. British Journal of Clinical Pharmacology. 71: 758-65. PMID 21204913 DOI: 10.1111/J.1365-2125.2010.03897.X  0.67
2011 Perrin-Terrin A, Pathak A, Lapeyre-Mestre M. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Fundamental & Clinical Pharmacology. 25: 503-10. PMID 20825488 DOI: 10.1111/J.1472-8206.2010.00871.X  0.335
2011 Moulis G, Béné J, Sommet A, Sailler L, Lapeyre-Mestre M, Montastruc J. Lupus induit par les statines : étude cas/non-cas dans la banque française de Pharmacovigilance La Revue De MéDecine Interne. 32: S292-S293. DOI: 10.1016/J.Revmed.2011.10.357  0.515
2011 Moulis G, Sommet A, Béné J, Montastruc F, Sailler L, Montastruc J, Lapeyre-Mestre M. Risque de cancer sous anti-TNF-α chez les patients adultes atteints de polyarthrite rhumatoïde : méta-analyse de 33 essais cliniques randomisés La Revue De MéDecine Interne. 32: S274-S275. DOI: 10.1016/J.Revmed.2011.10.322  0.516
2011 Moulis G, Sommet A, Bagheri H, Durrieu G, Lapeyre-Mestre M, Montastruc J. Notification des effets indésirables graves et non graves au cours du temps : étude dans la banque nationale française de pharmacovigilance La Revue De MéDecine Interne. 32: S133-S134. DOI: 10.1016/J.Revmed.2011.03.210  0.553
2011 Pugnet G, Arlet P, Bourrel R, Montastruc J, Lapeyre-Mestre M, Sailler L. Morbi-mortalité cardiovasculaire dans la maladie de Horton. Étude comparative en population générale chez 103 patients de la cohorte APOGEE La Revue De MéDecine Interne. 32: S66-S67. DOI: 10.1016/J.Revmed.2011.03.062  0.313
2011 Moulis G, Sailler L, Sommet A, Montastruc J, Lapeyre-Mestre M. Insuffisance rénale aiguë induite par les immunoglobulines polyvalentes intraveineuses : facteurs associés à la nécessité de dialyse La Revue De MéDecine Interne. 32: S61-S62. DOI: 10.1016/J.Revmed.2011.03.052  0.548
2011 Dupouy J, Moulis G, Tubery M, Ecoiffier M, Sommet A, Poutrain J, Arlet P, Lapeyre-Mestre M. Iatrogénie intra-hospitalière dans un service de médecine interne - post-urgences médicales La Revue De MéDecine Interne. 32: S61. DOI: 10.1016/J.Revmed.2011.03.051  0.685
2011 Boeuf-Cazou O, Pourcel L, Lapeyre-Mestre M. Impact d’une consommation modérée d’alcool sur les performances cognitives des salariés : résultats de la cohorte VISAT Archives Des Maladies Professionnelles Et De L'Environnement. 72: 189-195. DOI: 10.1016/J.Admp.2010.12.001  0.779
2010 Gallini A, Degris E, Desplas M, Bourrel R, Archambaud M, Montastruc JL, Lapeyre-Mestre M, Sommet A. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. The Journal of Antimicrobial Chemotherapy. 65: 2650-7. PMID 20876240 DOI: 10.1093/Jac/Dkq351  0.506
2010 Julians-Minou G, Bruch S, Peyre N, Sudérie G, Lapeyre-Mestre M, Roussin A. [Buprenorphine for the treatment of opioid dependence: a study on generic substitution conducted in community pharmacies]. Therapie. 65: 241-7. PMID 20699077 DOI: 10.2515/Therapie/2010012  0.317
2010 Montastruc JL, Durrieu G, Sommet A, Damase-Michel C, Lapeyre-Mestre M. Anticholinergics, antimuscarinics or atropinics? About the words in pharmacology. British Journal of Clinical Pharmacology. 69: 561-2. PMID 20573094 DOI: 10.1111/J.1365-2125.2010.03633.X  0.52
2010 Pradel V, Delga C, Rouby F, Micallef J, Lapeyre-Mestre M. Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator. Cns Drugs. 24: 611-20. PMID 20527997 DOI: 10.2165/11531570-000000000-00000  0.37
2010 Gardette V, Andrieu S, Lapeyre-Mestre M, Coley N, Cantet C, Ousset PJ, Grand A, Monstastruc JL, Vellas B. Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study. Cns Drugs. 24: 431-42. PMID 20369907 DOI: 10.2165/11318010-000000000-00000  0.715
2010 Fuzier R, Lapeyre-Mestre M. Safety of amide local anesthetics: new trends. Expert Opinion On Drug Safety. 9: 759-69. PMID 20367329 DOI: 10.1517/14740331003789373  0.302
2010 Montastruc G, Favreliere S, Sommet A, Pathak A, Lapeyre-Mestre M, Perault-Pochat MC, Montastruc JL. Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database. British Journal of Clinical Pharmacology. 69: 287-94. PMID 20233200 DOI: 10.1111/J.1365-2125.2009.03596.X  0.552
2010 Boeuf-Cazou O, Niezborala M, Marquie JC, Lapeyre-Mestre M. Factors associated with psychoactive drug initiation in a sample of workers in France: results of the VISAT cohort study. Pharmacoepidemiology and Drug Safety. 19: 296-305. PMID 20143339 DOI: 10.1002/pds.1911  0.798
2010 Tavassoli N, Voisin S, Carrie D, Lapeyre-Mestre M, Galinier M, Montastruc JL, Pathak A. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 10: 29-35. PMID 20104932 DOI: 10.2165/11318260-000000000-00000  0.678
2010 Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Montastruc J. Insuffisance rénale aiguë induite par les immunoglobulines polyvalentes intraveineuses : enquête descriptive à partir de la banque nationale française de pharmacovigilance La Revue De MéDecine Interne. 31: S359-S360. DOI: 10.1016/J.Revmed.2010.10.048  0.551
2009 Micallef-Roll J, Lapeyre-Mestre M. Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs? Therapie. 64: 355-64. PMID 27392928 DOI: 10.2515/Therapie/2009054  0.31
2009 Sommet A, Shams R, Valnet-Rabier MB, Jean-Pastor MJ, Castot A, Lapeyre-Mestre M, Montastruc JL. [Drugs and heat wave: SIRIUS, a multicentric case-control study in patients older than 65 years during 2007 summer in France]. Therapie. 64: 295-301. PMID 19863904 DOI: 10.2515/Therapie/2009044  0.569
2009 Tavassoli N, Lapeyre-Mestre M, Sommet A, Montastruc JL. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol). British Journal of Clinical Pharmacology. 68: 422-6. PMID 19740400 DOI: 10.1111/J.1365-2125.2009.03472.X  0.754
2009 Orriols L, Gaillard J, Lapeyre-Mestre M, Roussin A. Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France. Drug Safety. 32: 859-73. PMID 19722729 DOI: 10.2165/11316590-000000000-00000  0.37
2009 Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs & Aging. 26: 475-82. PMID 19591522 DOI: 10.2165/00002512-200926060-00004  0.358
2009 Do C, Huyghe E, Lapeyre-Mestre M, Montastruc JL, Bagheri H. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database. Drug Safety. 32: 591-7. PMID 19530745 DOI: 10.2165/00002018-200932070-00005  0.342
2009 Fuzier R, Lapeyre-Mestre M, Samii K, Montastruc JL. Adverse drug reactions to local anaesthetics: a review of the French pharmacovigilance database. Drug Safety. 32: 345-56. PMID 19388725 DOI: 10.2165/00002018-200932040-00008  0.366
2009 Boeuf-Cazou O, Lapeyre-Mestre M, Niezborala M, Montastruc JL. Evolution of drug consumption in a sample of French workers since 1986: the 'Drugs and Work' study. Pharmacoepidemiology and Drug Safety. 18: 335-43. PMID 19180587 DOI: 10.1002/pds.1713  0.805
2009 Brefel-Courbon C, Grolleau S, Thalamas C, Bourrel R, Allaria-Lapierre V, Loï R, Micallef-Roll J, Lapeyre-Mestre M. Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population. Pain. 141: 14-8. PMID 19062167 DOI: 10.1016/J.Pain.2008.04.026  0.308
2009 Sommet A, Lapeyre-Mestre M, Castot A, Montastruc J. Sirius : étude cas-témoins multicentrique française sur les médicaments et leurs posologies chez les plus de 65 ans en cas de forte chaleur Revue D'éPidéMiologie Et De Santé Publique. 57: S84. DOI: 10.1016/J.Respe.2009.07.048  0.522
2009 Gardette V, Cestac P, Cantet C, Reynish E, Lapeyre-Mestre M, Andrieu S, Vellas B. Comparaison européenne de la prescription de médicaments spécifiques antidémentiels : l’étude ICTUS Revue D'éPidéMiologie Et De Santé Publique. 57: S92. DOI: 10.1016/J.Respe.2009.07.003  0.716
2009 Gardette V, Cestac P, Andrieu S, Cantet C, Montastruc J, Nourhashemi F, Lapeyre-Mestre M, Vellas B. Profil d’utilisation des médicaments spécifiques antidémentiels et des psychotropes dans la maladie d’Alzheimer : l’étude Plasa Revue D'éPidéMiologie Et De Santé Publique. 57: S92. DOI: 10.1016/J.Respe.2009.07.002  0.708
2008 Molokhia M, Pathak A, Lapeyre-Mestre M, Caturla L, Montastruc JL, McKeigue P. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. British Journal of Clinical Pharmacology. 66: 386-95. PMID 18637888 DOI: 10.1111/J.1365-2125.2008.03229.X  0.372
2008 Sommet A, Grolleau S, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004? European Journal of Clinical Pharmacology. 64: 829-34. PMID 18509626 DOI: 10.1007/S00228-008-0497-3  0.565
2008 Sailler L, Attane C, Michenot F, Canonge JM, Rostaing L, Arlet-Suau E, Arlet P, Launay F, Montastruc JL, Lapeyre-Mestre M. Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey. British Journal of Clinical Pharmacology. 66: 320-2. PMID 18485050 DOI: 10.1111/J.1365-2125.2008.03193.X  0.305
2008 Micaleff J, Jolliet P, Victorri-Vigneau C, Mallaret M, Richard N, Haramburu F, Lapeyre-Mestre M. [First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development]. Therapie. 63: 55-65. PMID 18387277 DOI: 10.2515/Therapie:2008014  0.371
2008 Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Did thirst-blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave? Pharmacoepidemiology and Drug Safety. 17: 312-3. PMID 18300324 DOI: 10.1002/Pds.1548  0.482
2008 Montastruc J, Lugardon S, Desboeuf K, Fernet P, Lapeyre-Mestre M. Utilisation de la méthode capture-recapture pour l’évaluation de la fréquence des effets indésirables « graves » médicamenteux : l’expérience du CHU de Toulouse Bulletin De L'AcadéMie Nationale De MéDecine. 192: 421-431. DOI: 10.1016/S0001-4079(19)32840-7  0.305
2008 Gardette V, Andrieu S, Gillette-Guyonnet S, Nourhashémi F, Ousset PJ, Cantet C, Lapeyre-Mestre M, Montastruc J, Vellas B. P2-392: Predictive factors of discontinuation and switch of cholinesterase inhibitors in Alzheimer's disease Alzheimer's & Dementia. 4: T488-T488. DOI: 10.1016/J.Jalz.2008.05.1470  0.67
2007 Berthet S, Grolleau S, Brefel-Courbon C, Montastruc JL, Lapeyre-Mestre M. [Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database]. Therapie. 62: 483-8. PMID 18316014 DOI: 10.2515/Therapie:2007076  0.371
2007 Tavassoli N, Sommet A, Lapeyre-Mestre M, Bagheri H, Montrastruc JL. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). Drug Safety. 30: 1063-71. PMID 17973542 DOI: 10.2165/00002018-200730110-00005  0.774
2007 Biga J, Gony M, Bourrel R, Souche A, Sommet A, Pathak A, Sciortino V, Taboulet F, Grand A, Lapeyre-Mestre M, Montastruc JL. Coxibs: evolution of prescription's behaviour in France. Fundamental & Clinical Pharmacology. 21: 317-25. PMID 17521301 DOI: 10.1111/J.1472-8206.2007.00489.X  0.562
2007 Sommet A, Desplas M, Lapeyre-Mestre M, Montastruc JL. Drug-induced yawning: a review of the French pharmacovigilance database. Drug Safety. 30: 327-31. PMID 17408309 DOI: 10.2165/00002018-200730040-00005  0.586
2007 Boeuf O, Lapeyre-Mestre M. Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey. Drug Safety. 30: 265-76. PMID 17343432 DOI: 10.2165/00002018-200730030-00007  0.36
2007 Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. European Journal of Clinical Pharmacology. 63: 221-8. PMID 17225990 DOI: 10.1007/S00228-006-0242-8  0.767
2007 Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database. Pharmacoepidemiology and Drug Safety. 15: 735-40. PMID 16924603 DOI: 10.1002/Pds.1284  0.517
2007 Sailler L, Meliani P, Castex O, Arlet P, Adoue D, Blancher A, Lapeyre-Mestre M, Montastruc J, Saivin S, Pourrat J. Intérêt de la mesure des concentrations sanguines d'hydroxychoroquine et de son métabolite le déséthylhydroxychloroquine pour la prédiction des rechutes à un an au cours du lupus systémique. Étude chez 58 patients La Revue De MéDecine Interne. 28: 65. DOI: 10.1016/J.Revmed.2007.03.096  0.303
2006 Montastruc JL, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H. Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 629-32. PMID 17110152 DOI: 10.1016/J.Jbspin.2006.09.002  0.562
2006 Lugardon S, Roussel H, Bourrel R, Sciortino V, Montastruc JL, Lapeyre-Mestre M. [Patterns of non steroidal anti-inflammatory drug use in ambulatory care]. Therapie. 61: 109-14. PMID 16886702 DOI: 10.2515/Therapie:2006029  0.381
2006 Lugardon S, Desboeuf K, Fernet P, Montastruc JL, Lapeyre-Mestre M. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. British Journal of Clinical Pharmacology. 62: 225-31. PMID 16842398 DOI: 10.1111/J.1365-2125.2006.02633.X  0.332
2006 Roussin A, Mirepoix M, Lassabe G, Dumestre-Toulet V, Gardette V, Montastruc JL, Lapeyre-Mestre M. Death related to a recreational abuse of propofol at therapeutic dose range. British Journal of Anaesthesia. 97: 268. PMID 16831883 DOI: 10.1093/BJA/AEL168  0.571
2006 Montastruc JL, Sommet A, Olivier P, Bagheri H, Gony M, Lapeyre-Mestre M, Brefel-Courbon C, Ferreira J, Schmitt L, Senard JM, Rascol O. [Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]. Therapie. 61: 29-38. PMID 16792152 DOI: 10.2515/Therapie:2006011  0.572
2006 Carvajal A, Macias D, Sáinz M, Ortega S, Martín Arias LH, Velasco A, Bagheri H, Lapeyre-Mestre M, Montastruc JL. HMG CoA reductase inhibitors and impotence: two case series from the Spanish and French drug monitoring systems. Drug Safety. 29: 143-9. PMID 16454541 DOI: 10.2165/00002018-200629020-00004  0.387
2006 Guitton E, Montastruc JL, Lapeyre-Mestre M. Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients. European Journal of Clinical Pharmacology. 62: 243-9. PMID 16416303 DOI: 10.1007/S00228-005-0080-0  0.777
2006 Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Lapeyre-Mestre M, Muoz M, Sie P, Honorato J, Montastruc J, Bagheri H. Detection and Incidence of Drug-Induced Agranulocytosis in French and Spanish Hospital: a Prospective Analysis from Laboratory Signals Drug Safety. 29: 911-1010. DOI: 10.2165/00002018-200629100-00054  0.711
2006 Montastruc J, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H. La pharmacovigilance et l'évaluation du risque médicamenteux: intérêt, fonctionnement et méthodes Revue Du Rhumatisme. 73: 1021-1024. DOI: 10.1016/J.Rhum.2006.09.008  0.536
2005 Sommet A, Juillard-Condat B, Cestac P, Lapeyre-Mestre M, Montastruc JL. [Methods for the measurement of drug consumption: application to antibiotics]. Therapie. 60: 553-9. PMID 16555492 DOI: 10.2515/Therapie:2005077  0.586
2005 Biga J, Taboulet F, Lapeyre-Mestre M, Duguet AM, Vincent S, Montastruc JL. [Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals]. Thã©Rapie. 60: 401-7. PMID 16268440 DOI: 10.2515/Therapie:2005058  0.307
2005 Micallef J, Pradel V, Thirion X, Jolliet P, Lapeyre-Mestre M. [Use of the health insurance database by the centres for evaluation and information on pharmacodependance: examples, interests and future prospects]. Therapie. 59: 581-8. PMID 15789818 DOI: 10.2515/Therapie:2004100  0.372
2005 Armand C, Thirion X, Saillard C, Lapeyre-Mestre M, Lambert H. [Neocodion misuse: evolution between 1992 and 2002]. Therapie. 59: 547-53. PMID 15648308 DOI: 10.2515/Therapie:2004093  0.378
2005 Souchet E, Lapeyre-Mestre M, Montastruc JL. Drug related falls: a study in the French Pharmacovigilance database. Pharmacoepidemiology and Drug Safety. 14: 11-6. PMID 15508129 DOI: 10.1002/Pds.1038  0.377
2005 Montastruc J, Bagheri H, Lacroix I, Olivier P, Durrieu G, Damase-Michel, Lapeyre-Mestre M. Nouvelles méthodes d’étude du risque médicamenteux : l’expérience du Centre Midi-Pyrénées de Pharmacovigilance Bulletin De L Academie Nationale De Medecine. 189: 493-505. DOI: 10.1016/S0001-4079(19)33561-7  0.361
2004 Lapeyre-Mestre M, Sulem P, Niezborala M, Ngoundo-Mbongue TB, Briand-Vincens D, Jansou P, Bancarel Y, Chastan E, Montastruc JL. [Taking drugs in the working environment: a study in a sample of 2106 workers in the Toulouse metropolitan area]. Therapie. 59: 615-23. PMID 15789825 DOI: 10.2515/Therapie:2004107  0.349
2004 Bagheri H, Fouladi A, Barange K, Lapeyre-Mestre M, Payen JL, Montastruc JL, Vinel JP. Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy. Pharmacotherapy. 24: 1546-53. PMID 15537560 DOI: 10.1592/Phco.24.16.1546.50947  0.3
2004 Montastruc JL, Lapeyre-Mestre M, Gony M, Lugardon S, Bagheri H. [Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data]. Therapie. 59: 201-5. PMID 15366126 DOI: 10.2515/Therapie:2004039  0.342
2004 Pathak A, Senard J, Bujaud T, Bagheri H, Lapeyre-Mestre M, Tressieres M, Montastruc J. Medication error caused by confusing drug blisters. The Lancet. 363: 2142. PMID 15220039 DOI: 10.1016/S0140-6736(04)16507-0  0.329
2004 Dugué A, Bagheri H, Lapeyre-Mestre M, Tournamille JF, Sailler L, Dedieu G, Salvayre R, Thouvenot JP, Massip P, Montastruc JL. Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals. European Journal of Clinical Pharmacology. 60: 285-92. PMID 15114428 DOI: 10.1007/S00228-004-0760-1  0.373
2004 Sanz E, Hernández MA, Ratchina S, Stratchounsky L, Peiré MA, Lapeyre-Mestre M, Horen B, Kriska M, Krajnakova H, Momcheva H, Encheva D, Martínez-Mir I, Palop V. Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia). European Journal of Clinical Pharmacology. 60: 127-34. PMID 15022033 DOI: 10.1007/S00228-004-0739-Y  0.31
2003 Montastuc JL, Bongard V, Lapeyre-Mestre M. Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists. European Journal of Clinical Pharmacology. 59: 685-8. PMID 14556042 DOI: 10.1007/S00228-003-0648-5  0.36
2003 Roussel-Navarro V, Bagheri H, Montastruc JL, Taillefer G, Bez J, Lapeyre-Mestre M. [Economic impact of generic substitution in the southwest of France: study of prescription and delivery of generic drugs based on Caisse Primaire d'Assurance Maladie de la Haute-Garonne data ]. Therapie. 58: 175-7. PMID 12942863 DOI: 10.2515/Therapie:2003029  0.356
2003 Montastruc JL, Arnaud P, Barbier C, Berlin I, Gatignol C, Haramburu F, Lagier G, Lapeyre-Mestre M, Mallaret M, Micaleff J. [Pharmacologic criteria for medical substitution in opiate dependence]. ThéRapie. 58: 123-5. PMID 12942851 DOI: 10.2515/Therapie:2003017  0.357
2003 Gony M, Lapeyre-Mestre M, Montastruc JL. Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs. Clinical Neuropharmacology. 26: 142-5. PMID 12782916 DOI: 10.1097/00002826-200305000-00007  0.354
2003 Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Fundamental & Clinical Pharmacology. 16: 343-6. PMID 12608357 DOI: 10.1046/J.1472-8206.2002.00100.X  0.3
2003 Cestac P, Bagheri H, Lapeyre-Mestre M, Sié P, Fouladi A, Maupas E, Léger P, Fontan B, Massip P, Montastruc JL. Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients. Drug Safety. 26: 197-207. PMID 12580648 DOI: 10.2165/00002018-200326030-00005  0.321
2003 Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. British Journal of Clinical Pharmacology. 54: 665-70. PMID 12492616 DOI: 10.1046/J.1365-2125.2002.T01-3-01689.X  0.384
2003 Olivier P, Boulbés O, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Drug Safety. 25: 1035-44. PMID 12408734 DOI: 10.2165/00002018-200225140-00005  0.339
2002 Bongard V, Ménard-Taché S, Bagheri H, Kabiri K, Lapeyre-Mestre M, Montastruc JL. Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. British Journal of Clinical Pharmacology. 54: 433-6. PMID 12392593 DOI: 10.1046/J.1365-2125.2002.01674.X  0.331
2002 Simiand-Erdociain E, Lapeyre-Mestre M, Bagheri-Charabiani H, Montastruc JL. Drug consumption in a very elderly community-dwelling population. European Journal of Clinical Pharmacology. 57: 691-2. PMID 11791901 DOI: 10.1007/S002280100344  0.311
2001 Montastruc JL, Chaumerliac C, Desboeuf K, Manika M, Bagheri H, Rascol O, Lapeyre-Mestre M. Adverse drug reactions to selegiline: a review of the French pharmacovigilance database. Clinical Neuropharmacology. 23: 271-5. PMID 11154095 DOI: 10.1097/00002826-200009000-00006  0.358
2000 Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet (London, England). 356: 1735-6. PMID 11095263 DOI: 10.1016/S0140-6736(00)03209-8  0.332
1999 Lapeyre-Mestre M, Chastan E, Louis A, Montastruc JL. Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986). Journal of Clinical Epidemiology. 52: 471-8. PMID 10360343 DOI: 10.1016/S0895-4356(99)00008-6  0.398
1997 Lapeyre-Mestre M, Gary J, Machelard-Roumagnac M, Bonhomme C, Bugat R, Montastruc JL. Incidence and cost of adverse drug reactions in a French cancer institute. European Journal of Clinical Pharmacology. 53: 19-22. PMID 9349925 DOI: 10.1007/S002280050331  0.32
1997 Lapeyre-Mestre M, Damase-Michel C, Adams P, Michaud P, Montastruc JL. Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study. Community pharmacists of the Midi-Pyrénées. European Journal of Clinical Pharmacology. 52: 37-9. PMID 9143865 DOI: 10.1007/S002280050246  0.373
1995 Montastruc P, Damase-Michel C, Lapeyre-Mestre M, Puget C, Damase L, Hurstel J, Graille V, Montastruc J. A Prospective Intensive Study of Adverse Drug Reactions in Urban General Practice Clinical Drug Investigation. 10: 117-122. DOI: 10.2165/00044011-199510020-00007  0.344
1995 Muratet C, Lapeyre-Mestre M, Montastruc J. Study on the Regular Use of Drugs in Workers over 50 Years of Age Clinical Drug Investigation. 9: 1-7. DOI: 10.2165/00044011-199509010-00002  0.373
Show low-probability matches.